Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain

article OA: closed CC0 ⤵ 59 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-06

This study investigated the long-term efficacy and safety of leuprolide acetate with hormonal add-back therapy for managing chronic pelvic pain in patients with stage IV endometriosis over a 10-year period.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715mesh:D017699endometriosischronic_pelvic_pain

MeSH descriptors

Bone Demineralization, Pathologic Bone Demineralization, Pathologic Endometriosis Estradiol Leuprolide Pelvic Pain Progestins Adult Bone Demineralization, Pathologic Bone Density Bone Density Chronic Disease Drug Combinations Endometriosis Endometriosis Estradiol Female Fertility Agents, Female Fertility Agents, Female Hormone Replacement Therapy

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:18.313808+00:00
License: CC0 · commercial use OK